Swallowing therapy for patients with head neck cancer treated with chemoradiation therapy: A Randomized Control Trial
- Conditions
- Health Condition 1: C103- Malignant neoplasm of posterior wall of oropharynx
- Registration Number
- CTRI/2024/07/071024
- Lead Sponsor
- Sri Ramachandra Hospital and Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
It is proposed to enrol a cohort of HNC adults= 18 years of age, both sexes, newly diagnosed carcinoma of the oropharynx, hypopharynx, or supraglottic larynx with squamous cell carcinoma histology in stages T2-T4, N+, and M0. Patients who will have to be scheduled for chemotherapy with IMRT with a dose of 66 Gy in 33 fractions of the gross tumor volume and involved nodal disease over 6.5 weeks with chemotherapy and are willing to participate will be included.
Patients other than the oropharynx, hypopharynx, and supraglottic larynx or with distant metastasis will be excluded from the study. Also, patients with a history of recurrence, head and neck surgery, or surgery scheduled due to HNC or co-morbid neurological deficits or diseases affecting swallowing function will be excluded from the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method